8-K: Medicine Man Technologies Appoints Interim CFO Amid Ongoing Search

Medicine Man Technologies, Inc. has appointed Bob Finley of FLG Partners as its Interim Chief Financial Officer, effective April 21, 2025, while the company continues its search for a permanent CFO.

Summary

• Medicine Man Technologies, Inc. has retained Bob Finley, a partner at FLG Partners, as its Interim Chief Financial Officer, effective April 21, 2025.
• Mr. Finley's role is as a non-employee consultant while the company seeks a permanent CFO.
• The company will pay FLG Partners $100,000 per month for Mr. Finley's services under a 12-week consulting agreement, which may be extended with mutual consent.
• The agreement includes an indemnification clause for Mr. Finley and FLG Partners.
• Mr. Finley has over 25 years of experience as a CFO, primarily in venture-backed, high-growth companies, including those in the cannabis sector.

Sentiment

Score: 7

Explanation: The announcement is neutral to positive. It indicates a proactive approach to filling a key leadership position with an experienced professional, which can reassure investors. However, the interim nature of the role introduces some uncertainty.

Positives

• The appointment of an experienced Interim CFO like Bob Finley can provide stability and expertise during the search for a permanent CFO.
• Mr. Finley's background in venture-backed, high-growth companies, including cannabis, is relevant to Medicine Man Technologies' business.
• The consulting agreement allows for flexibility, with the possibility of extension beyond the initial 12-week term.

Risks

• The interim nature of the CFO position could create uncertainty or instability if the search for a permanent CFO takes longer than expected.
• The consulting agreement is subject to termination by either party with 30 days' notice, which could lead to abrupt changes in leadership.
• There is a risk that the company may have to pay a placement fee to FLG if they hire Mr. Finley as an employee or consultant within one year of the end of the engagement.

Future Outlook

The company is conducting an ongoing search for a permanent Chief Financial Officer.

Industry Context

The appointment of an interim CFO is a common practice in the corporate world, especially during transitions or when a company is undergoing significant changes. The cannabis industry, being relatively new and rapidly evolving, often sees companies bringing in experienced financial professionals to navigate the complexities of the market.

Comparison to Industry Standards

• The consulting fee of $100,000 per month for an interim CFO is within the typical range for publicly held companies, especially those in high-growth sectors.
• FLG Partners is a well-known CFO services firm, similar to other firms like CFO Systems and Tatum, which specialize in providing interim financial leadership.
• The 12-week term with a possible extension is a standard arrangement for interim executive roles, allowing both the company and the consultant to assess the fit and needs before committing to a longer period.

Management Changes

Stakeholder Impact

• Shareholders may view the appointment of an experienced Interim CFO positively, as it provides financial leadership during the search for a permanent replacement.
• Employees in the finance department will be working under the direction of Mr. Finley during his interim tenure.
• The appointment of an Interim CFO does not have a direct impact on customers, suppliers, or creditors.

Next Steps

• Medicine Man Technologies will continue its search for a permanent Chief Financial Officer.
• Mr. Finley will provide interim CFO services as outlined in Exhibit B of the consulting agreement.

Key Dates

Keywords

Interim CFO, Chief Financial Officer, FLG Partners, Medicine Man Technologies, Appointment, Consulting Agreement, Cannabis